{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicvv6q7cs2l2aj6uuzzt3wugiqld7hgrva3awtzud5lbqnqumraea",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3momlmdxxlaq2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihcw3xrsyasmj5vmoyo6hzwc3sn6mqage575tmtgvsyo2le75tgfe"
    },
    "mimeType": "image/jpeg",
    "size": 79566
  },
  "path": "/2026/06/18/fda-mrna-flu-vaccine-vrbpac-advisers-endorse-moderna-shots/?utm_campaign=rss",
  "publishedAt": "2026-06-18T20:26:25.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Pharma",
    "biotechnology",
    "FDA",
    "Moderna",
    "Pharmaceuticals",
    "public health",
    "STAT+"
  ],
  "textContent": "A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.",
  "title": "STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy",
  "updatedAt": "2026-06-18T21:01:30.000Z"
}